prednimustine
- CAS NO.:29069-24-7
- Empirical Formula: C35H45Cl2NO6
- Molecular Weight: 646.64
- MDL number: MFCD00866487
- EINECS: 249-410-3
- SAFETY DATA SHEET (SDS)
- Update Date: 2023-05-04 17:34:37
What is prednimustine?
Originator
Stereocyt, Bellon ,France ,1978
The Uses of prednimustine
Antineoplastic.
Definition
ChEBI: Prednimustine is a corticosteroid hormone.
Manufacturing Process
p-[N-bis(β-chloroethyl)amino] phenyl butyric acid was dissolved in a mixture of 150 ml dry benzene and 8.04 ml dry pyridine. The solution was cooled in an ice bath, and a solution of thionyl chloride in 30 ml dry benzene was slowly added with stirring under anhydrous conditions.
The reaction mixture was then kept at room temperature for 1 hour and thereafter poured into a mixture of 5.0 N HCl and crushed ice. The benzene solution was immediately washed with water, with cold 1.0 N NaHCO3 and finally with cold water. After drying over anhydrous sodium sulfate, the benzene was removed in vacuo. The residue is the p-[N-bis(βchloroethyl)amino]phenyl butyric anhydride which could be used without any further purification.
To a solution of 42.0 g of p-[N-bis(β-chloroethyl)amino]phenyl butyric anhydride in 500 ml dry pyridine was added 24.4 g of prednisolone. The reaction mixture was kept at room temperature for 24 hours under anhydrous condition. It was then poured into a mixture of concentrated HCl and crushed ice and extracted with ether-ethyl acetate (1:1).
The organic phase was washed several times with cold 1.0 N K2CO3 and finallywater. After drying over CaCl2 the solvent was removed in vacuo.
The residue is prednisolone 21-[4'-[p-bis(β-chloroethyl)amino]phenyl]butyrate which after crystallization from methanol/water had a melting point of 163°C to 164°C.
Therapeutic Function
Cancer chemotherapy
Properties of prednimustine
| Melting point: | 163-164° |
| Boiling point: | 791.5±60.0 °C(Predicted) |
| alpha | D24 +92.9° (c = 1.06 in chloroform) |
| Density | 1.30±0.1 g/cm3(Predicted) |
| pka | 12.32±0.70(Predicted) |
| IARC | 3 (Vol. 50) 1990 |
Safety information for prednimustine
Computed Descriptors for prednimustine
New Products
Pentadecanoic acid 3-Bromophenylacetic acid 3-AMINO-3-(2-FLUORO-PHENYL)-PROPIONIC ACID Hendecanoic acid 2-Bromo-5-cyanopyridine 2-Amino-5-cyanopyridine 4-(4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile 5-Bromo-4-chloro-3-indolyl-β-D-galactopyranoside Tetracaine Hydrochloride Ep Grade 2,2,2-Trichloroethyl chloroformate 3′-Hydroxyacetophenone 5-fluoro-1,3-benzodioxole 2-Bromo-6-fluoroaniline 2-Amino-4-phenyl-thiazole N-(4-Bromophenyl)-2-chloroacetamide 1-(3-Hydroxyphenyl)-2-thiourea 4-Nitrobenzenesulfonohydrazide 2-Aminobenzo[d]thiazol-4-ol 4-Chloro-2-methyl quinoline 5,11-Dihydro-10H-dibenzo[b,f]azepin-10-one-1,2,3,4-d4 5-amino-1-(2-chlorophenyl)-1H-pyrazole-4-carbonitrile ethyl 1-(6-chloropyridin-2-yl)-5-hydroxy-1H-pyrazole-4-carboxylate N-[-6,6-dimethyl-2-hepten-4-yn-1-yl]-N-(methyl-d3)-1-naphthalenemethanamine, monohydrochloride 2H-indol-2-one, 5-amino-1,3-dihydro-1-(1-methylethyl)-Related products of tetrahydrofuran








You may like
-
2407-11-6. 2-Chloro-6-nitro benzothiazole 98%View Details
2407-11-6. -
2-Amino-4-phenyl-thiazole 2010-06-2. 98%View Details
2010-06-2. -
2937-05-5. 4-Nitrobenzenesulfonohydrazide 98%View Details
2937-05-5. -
2564-02-5. 98%View Details
2564-02-5. -
2-(Chloromethyl) quinazolin-4(3H)-one 98%View Details
3817-05-8. -
5-Phenyl-[1,3,4]-thiadiazol-2-amine 2002-03-1. 98%View Details
2002-03-1. -
3394-05-6. 1-(3-Hydroxyphenyl)-2-thiourea 98%View Details
3394-05-6. -
4295-06-1. 98%View Details
4295-06-1.
